News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Oncolytics Biotech Inc. Successfully Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R)
April 30, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CALGARY, April 30 /CNW/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has successfully completed initial scale up of its manufacturing process for REOLYSIN(R).
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 1
Phase 2
Oncolytics Biotech Inc.
MORE ON THIS TOPIC
Deals
Novartis, Antares stars align in cancer deal that could top $1.9B
June 24, 2026
·
2 min read
·
Gabrielle Masson
Podcast
AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more
June 24, 2026
·
1 min read
·
Jef Akst
Bankruptcy
Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy
June 23, 2026
·
3 min read
·
Gabrielle Masson
Inflammatory bowel disease
Merck posts ‘encouraging’ Phase 3 ulcerative colitis data but Roche challenge looms
June 23, 2026
·
2 min read
·
Tristan Manalac
